Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.
Paysign Inc. (PAYS) delivers innovative prepaid card solutions and digital payment services for healthcare, corporate, and government sectors. This news hub provides investors with essential updates on the company’s financial performance and strategic direction.
Access real-time announcements including earnings reports, partnership developments, and product innovations. Our curated collection features regulatory filings, leadership changes, and market expansion updates critical for informed decision-making.
Discover comprehensive coverage of Paysign’s fintech advancements in patient affordability programs and integrated payment processing. Content spans merger activity, technology patents, and compliance updates, maintained for accuracy and relevance.
Bookmark this page for streamlined access to Paysign’s evolving financial narrative. Combine fundamental analysis with timely news to track the company’s position in competitive payment processing markets.
Paysign (NASDAQ: PAYS), a provider of prepaid card programs, patient affordability solutions, digital banking services and integrated payment processing, has scheduled its first quarter 2025 earnings conference call for May 8, 2025, at 5:00 p.m. ET.
The company will host a conference call with both U.S. and international dial-in options. Financial professionals interested in participating in the Q&A session must register via email by May 2, 2025. A replay of the call will be available until August 8, 2025.
Paysign (NASDAQ: PAYS), a leading provider of prepaid card programs, patient affordability solutions, digital banking services and integrated payment processing, has announced its participation in the upcoming Ladenburg Thalmann Technology Innovation EXPO25.
The company's CFO, Jeff Baker, will deliver a presentation at the event, which is scheduled to take place in New York City on Wednesday, May 21, 2025. Interested investors can find additional information and registration details on the event's website.
Paysign (NASDAQ: PAYS) reported strong financial results for full-year 2024, with total revenues reaching $58.38 million, up 23.5% from 2023. The company's net income was $3.82 million ($0.07 per diluted share), compared to $6.46 million ($0.12 per diluted share) in 2023.
Key highlights include:
- Adjusted EBITDA increased 43.3% to $9.62 million
- Added 16 new plasma centers, ending with 480 centers
- Added 33 net patient affordability programs, reaching 76 active programs
- Patient affordability revenue grew 214.5% year-over-year
- Ended 2024 with $10.77 million in unrestricted cash and zero debt
For Q4 2024, total revenues were $15.61 million, up 14.0% year-over-year. However, plasma revenue declined 6.2% to $10.80 million, while patient affordability revenue increased 156.5% to $4.31 million.
Paysign (NASDAQ: PAYS) has acquired the assets of Gamma Innovation , strengthening its position in plasma donor and pharmaceutical patient engagement technologies. The acquisition includes key assets such as a donor engagement app and a specialized CRM platform designed for the blood and plasma collection industry.
As part of this strategic move, Michael Ngo, former Managing Member of Gamma, has been appointed as Paysign's Chief Innovation Officer. The company also welcomes key team members including Howard Steidle, Bei Xu, and Sam Wang, bringing expertise in business strategy, AI-driven analytics, and software development.
The integration aims to enhance Paysign's engagement, compensation, and resource management solutions across core markets, particularly strengthening relationships with plasma clients and bolstering patient affordability solutions.
Paysign (NASDAQ: PAYS), a provider of prepaid card programs, patient affordability solutions, digital banking services and integrated payment processing, has scheduled its fourth quarter and full year 2024 earnings conference call for March 25, 2025, at 5:00 p.m. ET.
Financial professionals interested in participating in the Q&A session must register by emailing ir@paysign.com by March 21, 2025. A replay of the call will be available until June 25, 2025.
Paysign (NASDAQ: PAYS) has released its 2024 performance analysis for patient affordability solutions. The company's dynamic business rules feature, introduced in 2022, achieved significant results by saving pharmaceutical program sponsors over $100 million in 2024 through mitigating copay maximizer impacts with 97% accuracy.
Key 2024 achievements include: supporting 66+ retail and specialty pharmaceutical programs, assisting more than 500,000 unique patients (double compared to 2023), and contributing over $600 million toward prescription fulfillment expenses. The company's patient affordability platform offers configurable tools for copay assistance programs and pharmaceutical manufacturers' brand strategies, featuring real-time modifications to program criteria.
Paysign (NASDAQ: PAYS) reported strong Q3 2024 results with total revenues of $15.26 million, up 23.0% year-over-year. Net income reached $1.44 million ($0.03 per diluted share), compared to $1.10 million ($0.02 per diluted share) in Q3 2023. The company's performance was driven by growth in plasma centers (478 total) and patient affordability programs (66 active). Pharma patient affordability revenue increased by 219.1%, while plasma revenue grew by 3.4%. The company maintains a strong financial position with $10.29 million in unrestricted cash and zero debt. Management reaffirmed full-year 2024 guidance with expected revenues of $56.5-58.5 million.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, patient affordability offerings, digital banking services, and integrated payment processing, has announced its upcoming third quarter 2024 earnings call. The call is scheduled for Tuesday, November 5, 2024, at 5:00 p.m. Eastern time.
Participants can join via U.S. dial-in at 877.407.2988 or international dial-in at +1.201.389.0923. A webcast link is also provided. A replay will be available until February 5, 2025, accessible through dial-in numbers 877.660.6853 or +1.201.612.7415 with Conference ID 13749532.
Financial professionals wishing to ask questions during the call should email ir@paysign.com by 5:00 p.m. Eastern time on Friday, November 1, 2024, to register.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs and financial services, has announced its participation in the Sidoti Micro-Cap Virtual Conference scheduled for August 14-15, 2024. The company's Chief Financial Officer, Jeff Baker, will be available for one-on-one and small group meetings with investors during the event.
Paysign is set to deliver a group presentation on Wednesday, August 14, at 4:00 p.m. EDT. Investors interested in attending can register through the event website or the webinar registration page to join the live presentation. This conference provides an opportunity for investors to gain insights into Paysign's operations and future prospects in the prepaid card and digital banking sector.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs and financial services, has announced its participation in the Oppenheimer 27th Annual Technology, Internet & Communications Conference. The virtual event, scheduled for August 12-14, 2024, aims to showcase existing and emerging technologies in the dynamic sector of the world economy.
Paysign's Chief Financial Officer, Jeff Baker, is set to present on Tuesday, August 13, at 3:45 p.m. EDT. This conference provides an opportunity for potential investors to evaluate public companies at the forefront of technological innovations. Interested parties can find more information about the conference through the provided link.
